By contrast, data related to VRK2 expression identify a subgroup of primary high-grade astrocytomas with a better prognosis [25], and results obtained from 136 cases of human breast carcinoma showed that VRK2 downregulation contributes to breast cancer phenotype [20]. The gene discussed is VRK2; the disease is astrocytoma (excluding glioblastoma).